Brief interest in HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) down 5.0%
HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE – Get Rating ) saw a significant decline in short interest in March. As of March 31, there was short interest on a total of 6,240,000 shares, a decrease of 5.0% from a total of 6,570,000 shares on March 15. Based on an average daily trading volume of 1,400,000 shares, the short interest ratio is currently 4.5 days. Approximately 7.6% of the shares in the stock are sold short.
HIVE Blockchain Technologies stock performance
HIVE stock opened at $3.34 on Friday. The company’s 50-day moving average is $3.13 and the 200-day moving average is $2.79. The company has a gearing ratio of 0.19, a gearing ratio of 2.86 and a quick ratio of 2.86. HIVE Blockchain Technologies has a 1 year low of $1.36 and a 1 year high of $9.30.
Hedge funds weigh in on HIVE Blockchain technologies
Institutional investors and hedge funds have recently made changes to their positions in the stock. Tower Research Capital LLC TRC lifted its position in HIVE Blockchain Technologies by 154.6% in the 3rd quarter. Tower Research Capital LLC TRC now owns 15,072 shares of the company’s stock valued at $56,000 after buying an additional 9,153 shares in the last quarter. Captrust Financial Advisors lifted its position in HIVE Blockchain Technologies by 786.9% in the 3rd quarter. Captrust Financial Advisors now owns 10,448 shares of the company’s stock valued at $39,000 after buying an additional 9,270 shares in the last quarter. Almanack Investment Partners LLC. bought a new position in HIVE Blockchain Technologies in the 3rd quarter valued at about $44,000. UBS Group AG lifted its position in HIVE Blockchain Technologies by 174.5% in the 3rd quarter. UBS Group AG now owns 17,829 shares of the company’s stock valued at $67,000 after buying an additional 11,333 shares in the last quarter. Finally, State Street Corp raised its stake in HIVE Blockchain Technologies by 3.4% in the 3rd quarter. State Street Corp now owns 348,212 shares of the company’s stock valued at $1,309,000 after purchasing an additional 11,481 shares during the last quarter. Institutional investors own 12.55% of the company’s shares.
Wall Street analysts predict growth
A number of research firms have recently weighed in on HIVE. Canaccord Genuity Group restated a “buy” rating and issued a $7.00 price objective on shares of HIVE Blockchain Technologies in a report on Wednesday, March 22nd. HC Wainwright restated a “buy” rating and issued a $5.00 price objective on shares of HIVE Blockchain Technologies in a report on Wednesday, February 22nd.
About HIVE Blockchain Technologies
(Get rating)
HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden and Iceland. It mines and sells digital currencies, including Ethereum, Ethereum Classic, and Bitcoin. The company was formerly known as Leeta Gold Corp. and changed its name to HIVE Blockchain Technologies Ltd.
Further reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial staff prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider HIVE Blockchain Technologies, you want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and HIVE Blockchain Technologies was not on the list.
While HIVE Blockchain Technologies currently has a “Buy” rating among analysts, top-rated analysts believe that these five stocks are better buys.
See the five stocks here
